|
業務類別
|
Biotechnology |
|
業務概覽
|
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition. |
| 公司地址
| 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494 |
| 電話號碼
| +1 781 292-4200 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.verastem.com |
| 員工數量
| 80 |
| Dr. Michael Glen Kauffman, M.D.,PhD |
Director and President, Development |
-- |
04/03/2026 |
| Mr. Daniel Paterson |
Director, President and Chief Executive Officer |
美元 648.00K |
04/03/2026 |
| Mr. Daniel Calkins |
Chief Financial Officer and Chief Accounting Officer |
美元 325.00K |
04/03/2026 |
|
|
| Mr. Anil Kapur |
Independent Director |
04/03/2026 |
| Dr. Eric K. Rowinsky,M.D. |
Independent Director |
04/03/2026 |
| Mr. John H. Johnson |
Chairman of the Board |
04/03/2026 |
| Dr. Michael Glen Kauffman, M.D.,PhD |
Director and President, Development |
04/03/2026 |
| Mr. Robert Gagnon, M.B.A. |
Director |
04/03/2026 |
| Mr. Brian M. Stuglik, R.Ph. |
Director |
04/03/2026 |
| Mr. Daniel Paterson |
Director, President and Chief Executive Officer |
04/03/2026 |
| Ms. Michelle J. Robertson |
Independent Director |
04/03/2026 |
| Dr. Paul Bunn, M.D. |
Independent Director |
04/03/2026 |
| Dr. Karin Tollefson, Pharm.D. |
Independent Director |
04/03/2026 |
|
|
|
|
